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Abstract
Three drugs effective against myxosporeans and commonly used to treat spore-forming para-
sites were tested in sharpsnout sea bream (Diplodus puntazzo) infected by Enteromyxum leei.
Two medicated diets were applied, one containing salinomycin and amprolium and the second
containing fumagillin. Compared to untreated fish, both treatments resulted in significant reduc-
tions in prevalence, intensity of all developmental myxosporean stages, and mortality. The effect
was more prominent with the salinomycin and amprolium combination, where the significant
reductions in intensity, prevalence, and mortality were unaccompanied by any histopathological
evidence of toxic side effects or growth reduction. Sporoblasts and mature spores with distorted
structures were observed in both drug treatments, but were more prevalent in the salinomycin
and amprolium treatment than in the fumagillin treatment, indicating direct effectiveness on the
parasite. Salinomycin with amprolium is a promising treatment for myxosporean infections in
intensively cultured warmwater fish, leading to parasite elimination. 
Introduction 
The recent growth of the aquaculture industry
in Greece, together with the introduction of
new fish species (Diplodus puntazzo C., D.
sargus, Dentex dentex, and Pagellus erythri-
nus) in intensive rearing systems, has led to
increased occurrence of pathogens that
cause serious problems and limit develop-
ment (Alvarez-Pellitero and Sitja-Bobadilla,
1993ab; Diamant et al., 1994; Diamant and
Wajsbrot, 1997; Rigos et al., 1999;
Golomazou et al., 2005). Myxosporeans, the
most common parasites affecting intensively
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reared fish in the Mediterranean, induce a
broad spectrum of diseases depending on
parasite species, host sensitivity, and environ-
mental and feeding conditions (Sitja-Bobadilla
et al., 1992; Alvarez-Pellitero and Sitja-
Bobadilla 1993ab; Rigos et al., 1997). Recent
losses in cultured sharpsnout seabream (D.
puntazzo) due to the marine myxosporean
Enteromyxum leei Diamant, Lom and Dykova,
1994 (formerly Myxidium leei) have raised
questions about the viability of farming this
species in Mediterranean mariculture (Rigos
et al., 1999). Enteromyxum leei also infects
Sparus aurata L. (Diamant 1992, 1997;
Diamant et al., 1994), Pagrus major L. (Le
Breton and Marques, 1995), and P. pagrus L.
(Diamant, 1995).
High mortality rates are associated with
the absence of adequate treatments for
warmwater fish. In contrast to mammalian
therapeutics, the use of pharmaceutical sub-
stances, particularly antiparasitic drugs, is lim-
ited in fish. Research on anti-myxosporean/
microsporean treatments mainly concern
salmonids and there is little research on
Mediterranean fish. There are no licensed
antiparasitic compounds or official minimal
residue levels (MRL) for Mediterranean
species; all information is extrapolated from
coldwater species, especially salmonids. This
can cause problems since treatments differ
depending on environmental (temperature,
pH, stability, toxicity to other aquatic animals)
and biological factors (species, safety, metab-
olism, stress, residues). 
The purpose of this study was to assess
the anti-myxosporean effects of commercially
available drugs used in other animals to treat
spore-forming parasites on sharpsnout sea
bream spontaneously infected with E. leei. 
Materials and Methods 
Fish. Three thousand infected Diplodus pun-
tazzo (mean wt 15 g) were obtained from a
sea cage on a commercial farm in northwest-
ern Greece where E. leei infection was diag-
nosed by clinical signs (acute enteritis,
anorexia, extensive emaciation) and high mor-
tality. The fish were naturally infected with E.
leei (prevalence 100%). The infection was
confirmed in ten fish by parasitological exami-
nation. Trophozoites, sporoblasts, and mature
parasite spores were found in fresh scrapings
of the gut mucosa of the posterior intestine. 
The fish were separated into three equal
groups. Each group was placed in an 8-ton
concrete raceway tank with a flow-through
supply of pathogen-free bore-hole water at a
temperature of 21±1°C, salinity 30‰, and pH
7. Fish were acclimatized for 7-10 days.
Before the start of the experiment, 30 fish (10
from each group) were sampled for bacteriol-
ogy and parasitology.
Diets. Fish in tank A were fed a medicated
diet containing salinomycin (70 mg/kg bio-
mass) and amprolium (100 mg/kg biomass),
two anti-coccidial drugs commonly used to
treat spore-forming parasites, especially in
poultry, for 56 days. Fish in tank B were fed a
medicated diet containing bicyclohexyl-
ammonium fumagillin (6 mg/kg biomass), a
commonly used anti-myxosporean drug, for
56 days. Fish in tank C (control) were fed a
regular non-medicated diet. The drug com-
pounds were of commercial grade (Table 1),
diluted in cod liver oil and coated onto com-
mercial feed pellets with a mechanical mixer.
Control fish were fed the same diet mixed with
the same quantity of cod liver oil. The diets
were freshly prepared before feeding and fed
to the fish by hand.
Sampling. Mortality and the presence of
clinical signs were recorded daily throughout
the experiment. In eight weekly samplings,
ten fish from each tank were sampled,
weighed, killed by an overdose of anesthetic,
and examined as follows.
Microbiological and parasitological exami-
nation. Kidney and spleen samples were inoc-
ulated onto tryptone soy agar (TAS) supple-
mented with NaCl 2% and thiosulphate citrate
bile salt agar (TCBS) for bacteriological exam-
ination according to methods described by
Roberts and Shepherd (1997). Fresh scrap-
ings and smears of internal organs (posterior
intestine, gall bladder, kidney, liver, spleen,
heart) and gills were examined according to
methods described by Roberts (1989).
Infection prevalence was assessed in ten ran-
dom samples from each tank at each sam-
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pling in ten random viewing fields per slide
(magnification x 400).
Infection intensity was estimated by count-
ing the spores in each myxosporean stage per
viewing field in fresh scrapings of the posteri-
or intestine of ten fish from each group at each
sampling. Spores were counted in ten random
viewing fields per slide (magnification x 400).
Intensity was arbitrarily classified into four lev-
els: A = 1-5, B = 6-10, C = 11-15, and D >15
spores/field. Dry smears of organs were
stained with Giemsa (Drury and Wallington
1980).
Histological examination. Gill, kidney,
digestive tract (esophagus, stomach, and
anterior, middle, and posterior parts of the
intestine), liver, spleen, gall bladder, and heart
tissues of five fish from each group in each
sampling were processed histologically. The
tissues were fixed in 10% buffered formalin,
processed, and stained with hematoxylin and
eosin (H&E; Merck, Darmstadt, Germany) and
Giemsa-Von Kossa (Merck) according to stan-
dard methods (Drury and Wallington, 1980).
Statistical analysis. Analysis of variance
(ANOVA) and non-parametric tests (NPT)
were used to test for statistically significant
changes in measured data over time and
between groups. The effects of treatment on
the prevalence of parasites was studied using
the General Lineal Model (GLM) of repeated
measures (GLM-RM) or GLM univariate
analysis (two-way ANOVA). Where appropri-
ate, post hoc Games-Howell tests were per-
formed to reveal statistically significant differ-
ences between groups. One-way ANOVA with
the Welch statistic due to unequal variances
was used to test for the mortality equality of
group means for the 56 days. The NPT
Kruskal-Wallis χ2 test was used to confirm dif-
ferences in group mortality and compare body
weights between groups. Analyses were per-
formed with the Statistical Package for the
Social Sciences (SPSS Inc., Chicago, Illinois,
Windows ver. 12.0) and differences were con-
sidered statistically significant when p<0.05. 
Results 
Prevalence. At the beginning of the experi-
ment, the prevalence of E. leei infection in all
groups was 100%, based on the presence of
all developmental myxosporean stages in
fresh scrapings of the gut mucosa of the pos-
terior intestine. By the end of the experiment,
the prevalence dropped in groups A and B but
remained high in the control (Fig. 1). There
were sporoblasts and mature spores with dis-
torted structures in the treated groups but not
in the control (Figs. 2-4).
Intensity. The intensity of the infection was
estimated by observing the frequency of the
developmental myxosporean stages in fresh
scrapings of the gut mucosa of the posterior
intestine (Figs. 5-7).
Growth and mortality rates. Extensive
emaciation and hemorrhage in the intestinal
mucosa were observed in all dead fish. The
cumulative mortality rate was 18.82% for
group A, 25.04% for group B, and 39.7% in
the control (Fig. 8). Body weight, an indication
of the general well-being of the fish, did not
significantly differ between groups.
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Drug Commercial form (composition) Trade name Company
Amprolium Medicated premix (50%) Amprolium Veterin
Fumagillin Powder oral solution (20 mg/g) Fumidil® CEVA
(dicyclohexylamine)
Salinomycine Medicated premix (12%) Salinomycin Haechst
(salinomycine sodium)
Table 1. Drugs used in experimental treatments.
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Statistical analysis. There were significant
effects (GLM-RM) of drug treatment on total
mature spores in terms of both treatment
(F2,27 = 749.12; p = 0.000) and time (F8,216 =
928.73; p = 0.000). The post hoc test revealed
a significant difference in total mature spores
between the control group and groups B
(13.3±1.1; p = 0.000) and A (42.2±1.1; p =
0.000). Significant interactions between treat-
ment and time were observed (F8,216 =
372.35; p = 0.000). The differences between
the three groups were significant except for
weeks 4 and 5. For the total 56 days, the
mean percent of mature spores was
78.89±0.85 in the control group, 65.56±0.85
in group B, and 36.67±0.85 in group A. 
The same results were obtained with two-
way ANOVA. The effects on total mature
spores were significant for both treatment
(F2,243 = 653.078; p = 0.000) and time (F8,243
= 378.32; p = 0.000) and the total mature
spores of the control group significantly dif-
fered from those of groups B (13.3±1.12; p =
0.000) and A (42.2±1.12; p = 0.000). The
interaction between treatment and time was
also statistically significant (F16,243 = 18.32; p
= 0.000). 
The effects on total trophozoites were sig-
nificant for both treatment (F2,243 = 228.34; p
= 0.000) and time (F8,243 = 118.34; p = 0.000)
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Fig. 1. Prevalence of Enteromyxum leei (a) trophozoites, (b) sporoblasts, and (c) mature spores in sharp-
snout seabream treated with diets containing amprolium/salinomycin, fumagillin, or no anti-coccidial drug
(control). 
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with a significant difference between total
trophozoites in the control group and in group
A (21.0±3.1; p = 0.000). The opposite was
observed between the control group and
group B (-6.8±2.7; p = 0.038, Games-Howell). 
Effects on total sporoblasts were likewise
significant for both treatment (F2,243 =
630.58; p = 0.000) and time (F8,243 =
306.92; p = 0.000) with a significant difference
between total sporoblasts of the control group
and group A (21.0±3.1;,p = 0.000). There was
a significant interaction between treatment
and time (F8,243 = 41.90; p = 0.000). The post
hoc test revealed a significant difference
between total sporoblasts in the control group
and in group A (32.2±4.2; p = 0.000) although
the difference between the control group and
group B was not significant (-7.8±3.6; p =
0.081, Games-Howell) except during the last
week (one-way ANOVA, -20.0±6.1; p = 0.017,
Games-Howell).
Mortality significantly differed between
groups (χ2 = 44.093, d.f. 2, p = 0.000; F2,107 =
30.66, p = 0.000). Mean fish death per day
was 5.875±0.225 in the control, 3.964±0.262
in group B, and 2.982±0.332 in group A. The
differences were 1.91±0.34 between the con-
trol and group B (p = 0.000) and 2.89±0.40
between the control and group A (p = 0.000). 
There were no statistically significant dif-
ferences in body weight between the control
and the treated groups (χ2 = 1.191, d.f. 2, p =
0.551). 
Histopathology of E. leei. The fish in all
groups were intensely infected before treat-
ment, as were the fish in the control at the end
of the experiment. Pathology included degen-
eration, apoptosis, and necrosis in the epithe-
lial layer of the intestine and hemorrhage in
the mucosal layer (Fig. 9). There was an
inflammatory reaction near early trophozoites
in the mucosal layer that remained until the
parasite reached the sporoblast stage. The
epithelium of the gall bladder was degenerat-
ed and all stages of the parasite were present
in the lumen. 
Histological sections of all the fish were
compared with sections of uninfected healthy
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Fig. 2. Prevalence of distorted Enteromyxum leei (a) sporoblasts and (b) mature spores in sharpsnout
seabream treated with diets containing amprolium/salinomycin, fumagillin, or no anti-coccidial drug (control).
100
80
60
40
20
0
Untreated control group
Fumagillin treated group
Amprolium and salinomycin treated group
Day
Sp
or
ob
la
st
s
0 7 14 21 28 35 42 49 56
100
80
60
40
20
0
Day
M
at
ur
e 
sp
or
es
0 7 14 21 28 35 42 49 56
a b
162
fish. In contrast to the control fish, fish in group
A had few visible spores in the intestinal tract
after treatment and no pathological lesions in
any of the organs. Renal lesions were
observed only in fish from group B. There was
slight inflammation in the interstitial renal tissue
in these fish and, in a few cases, hemorrhage
and congestion in the liver. The glomerular
capsule was thickened in all group B fish.
Discussion
Treatment of fish myxosporidioses is a prob-
lem (Molnar, 1993). This study compares the
therapeutic outcomes of two antiparasitic
medicated feeds. Treatment success is mea-
sured by changes in prevalence and intensity
of each developmental myxosporean stage
and the mortality rate of the fish. Both treat-
ments resulted in a significant reduction of the
prevalence and frequency of developmental
myxosporean stages and fish mortality when
compared to the untreated control. Further,
sporoblasts and mature spores with distorted
structures were observed only in the treated
fish and not in the untreated control.
The combination of salinomycin and
amprolium (group A) was the more effective
treatment. Salinomycin is an antimicrobial
agent belonging to the ionophores. It is a high-
ly lipophilic polyether that accumulates in cell
membranes and catalyzes rapid potassium
movement, disturbing its intracellular balance
and killing sensitive microorganisms (Russell
and Houlihal, 2003). Oral administration of
salinomycin to tapir fish (Gnathonemus peter-
sii) naturally infected with the gill parasite,
Henneguya sp., caused irreversible damage
to the plasmodial developmental stages of the
parasite (Dohle et al., 2002). Amprolium is a
structural analogue of thiamine (vitamin B1)
that causes competitive inhibition of thiamine
utilization by parasites. It acts upon the first
Golomazou et al.
Fig. 3. (a) Normal sporoblasts, (b) distorted sporoblasts, (c) normal mature spores, and (d) distorted
mature spores of Enteromyxum leei in fresh scrapings of gut mucosa of the posterior intestine of sharpsnout
seabream treated with a diet containing amprolium and salinomycin; samples stained with Giemsa (x 400).
Fig. 4. (a) Normal sporoblasts, (b) distorted sporoblasts, (c) normal mature spores, and (d) distorted
mature spores of Enteromyxum leei in fresh scrapings of gut mucosa of the posterior intestine of sharpsnout
seabream treated with a diet containing bicyclohexyl-ammonium fumagillin; samples stained with Giemsa (x
400).
a b c d
a b c d
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Fig. 5. Number of Enteromyxum leei spores per viewing field in fresh scrapings of gut mucosa of the pos-
terior intestine of sharpsnout seabream treated with a diet containing amprolium and salinomycin; mean of
10 random viewing fields per slide (x 400).
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Fig. 6. Number of Enteromyxum leei per viewing field in fresh scrapings of gut mucosa of the posterior
intestine in sharpsnout seabream treated with a diet containing fumagillin; mean of 10 random viewing fields
per slide (x 400).
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coccidian generation, preventing differentia-
tion of merozoites. It may also suppress sex-
ual stages and sporulation of oocysts.
Amprolium is one of the safest anti-coccidian
drugs and is used extensively in the poultry
industry (Hamamoto et al., 2000). However,
amprolium was ineffective as a monotherapy
against many parasitic diseases in rainbow
trout (Tojo and Santamarina, 1998abc;
Speare et al., 1999). In the present study, the
combination of salinomycin and amprolium
resulted in a greater reduction of prevalence
and maintained the intensity of infection at a
lower level than fumagillin.
Combination treatments are well known for
several pathogens (Haberkorn, 1996; Croft,
1997). Salinomycin/amprolium treatment
proved successful in myxosporean infections
of Myxobolus sp. in D. puntazzo
(Athanassopoulou et al., 2004a) and Poly-
sporoplasma sparis in Sparus aurata
(Athanassopoulou et al., 2004b; Karagouni et
al., 2005). At the doses used in the experiment,
the combination caused no histopathological
lesions in the organs of the treated fish. The
effects of the combination may be attributed to
direct cytotoxic action on the parasite and influ-
ence on the host’s innate immunity enabling
effective defense mechanisms to eliminate the
parasite (Karagouni et al., 2005).
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Fig. 7. Number of myxosporean stages per viewing field in fresh scrapings of gut mucosa of the poste-
rior intestine among untreated (control) fish; mean of 10 random viewing fields per slide (x 400).
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Although fumagillin and its analogue
TNP-470 have produced promising results in
the control of Microsporea and Myxosporea
parasites in several fish species (Molnar et
al., 1987; Hedrick et al., 1988, 1991; Higgins
and Kent, 1988; Kent and Dawe, 1994;
Speare et al., 1999), it proved less effective
than salinomycin/amprolium in this study.
Nevertheless, fumagillin reduced the intensi-
ty of the infection compared to the control.
Fumagillin is effective against Myxidium gia-
rdi (Szekely et al., 1988) and Thelohanellus
hovorkai and Sphaerospora renicola in com-
mon carp when administrated during the
infective period (Molnar et al., 1987;
Yokoyama et al., 1999) or when early intra-
cellular trophozoites and more developed
plasmodia of Hoferellus carassi exist
(Yokoyama et al., 1990). It has been used
against Myxobolus cerebralis and PKX in
rainbow trout (El-Matbouli and Hoffman,
1991) and the myxosporean Sphaerospora
testicularis in sea bass (Sitja-Bobadilla and
Alvarez-Pellitero, 1992).
Fumagillin is an expensive drug and toxic
in high doses (Athanassopoulou et al., 2004
ab). Side effects range from inappetence to
mortality (Sitja-Bobadilla and Alvarez-
Pellitero, 1992). The most commonly reported
side effects are moderate and include growth
reduction in rainbow trout during treatment
(Kent and Dawe, 1994) and depletion of the
renal interstitium and vacuolation in the
epithelium of the renal tubules in chinook
salmon (Hedrick et al., 1988).
In conclusion, this is the first time that the
combination of salinomycin and amprolium
proved to be a safe and effective treatment
against E. leei infections in D. puntazzo. This
combination is a promising drug treatment for
myxosporean infections in intensively cultured
Mediterranean fish. The combination caused
no histopathological lesions in the organs of
treated fish for the doses used in the experi-
ment. Its effects may be attributed to both a
direct cytotoxic action of the drug on the para-
site and an immunostimulatory effect on the
host’s innate immunity resulting in parasite
elimination via effective defense mechanisms
(Karagouni et al., 2005). 
Golomazou et al.
Fig. 8. (a) Mortality rate and (b) mean weight of sharpsnout seabream infected by Enteromyxum leei in
treated and untreated groups.
Untreated control
Fumagillin treatment
Amprolium/salinomycin treatment
a b
D
ai
ly 
m
or
ta
lity
 (%
)
1.00
0.80
0.60
0.40
0.20
0.00
Day
0 10 20 30 40 50 60
M
ea
n 
w
t (g
)
Day
40
35
30
25
20
15
10
5
0
0 7 14 21 28 35 42 49 56
References
Alvarez-Pellitero P. and A. Sitza-Bobadilla,
1993a. Pathology of Myxosporea in marine
fish culture. Dis. Aquat. Org., 17:229-238. 
Alvarez-Pellitero P. and A. Sitza-Bobadilla,
1993b. Ceratomyxa spp. (Protozoa:
Myxosporea) infections in wild and cultured
sea bass, Dicentrarchus labrax, from the
Spanish Mediterranean area. J. Fish Biol.,
42:889-901.
Athanassopoulou F., Karagouni E., Dotsika
E., Ragias V., Tavla J., Christofilloyianis P.
and I. Vatsos, 2004a. Efficacy and toxicity of
orally administered anticoccidial drugs innova-
tive treatments of Myxobolus sp. infection in
167Effects of anti-coccidial drugs on Enteromyxum leei infection in seabream
Fig. 9. Histological section of intestine of sharpsnout seabream infected
with Enteromyxum leei showing (a) degeneration, apoptosis, and hemor-
rhage in the epithelial layer, and (b) degeneration, apoptosis, and granulo-
mata formation hemorrhage in the mucosal layer. H&E, x 400.
a
b
168
Puntazzo puntazzo. Dis. Aquat. Org., 62:217-
226.
Athanassopoulou F., Karagouni E.,
Dotsika E., Ragias V., Tavla J. and P.
Christofilloyanis, 2004b. Efficacy and toxici-
ty of orally administered anticoccidial drugs
innovative treatments of Polysporoplasma
sparis (Sitza-Bobadilla and Alvarez-Pellitero
1985) infection in Sparus aurata L. J. Appl.
Ichthyol., 20:345-354.
Croft S.L., 1997. The current status of
antiparasite chemotherapy. Parasitology, 114:
3-15.
Diamant A., 1992. A new pathogenic histo-
zoic Myxidium (Myxosporea) in cultured gilt-
head sea bream Sparus aurata. Bull. Eur.
Assoc. Fish Pathol., 12:64-66. 
Diamant A., 1995. Myxidium leei (Myxosporea)
infections in sharpsnout seabream Diplodus
puntazzo C. and common sea bream Pagrus
pagrus L. (Sparidae). Program and Book
Abstract, Abs. 8. IV Int. Symp. Fish Parasitol-
ogy, Oct., Munich. 
Diamant A., 1997. Fish-to-fish transmission
of a marine myxosporean. Dis. Aquat. Org.,
30:99-105. 
Diamant A. and N. Wajsbrot, 1997.
Experimental transmission of Myxidium leei in
gilthead sea bream Sparus aurata. Bull. Eur.
Assoc. Fish Pathol., 17:99-103.
Diamant A., Lom J. and I. Dykova, 1994.
Myxidium leei n. sp. a pathogenic myxospore-
an of cultured sea bream Sparus aurata. Dis.
Aquat. Org., 20:137-141.
Dohle A., Schmahl G., Raether W., Schmidt
H. and G. Ritter, 2002. Effects of orally
administered chemotherapeutics (quinine,
salinomycin) against Henneguya sp.
Thelohan, 1892 (Myxozoa: Myxobolidae), a
gill parasite in the tapir fish Gnathonemus
petersii Gunther, 1862 (Teleostei). Parasitol.
Res., 88:861-867.
Drury R.A. and E.A. Wallington (eds.),
1980. Carleton’s Histological Techniques.
Oxford Univ. Press, Oxford. 520 pp. 
El-Matbouli M. and R.W. Hoffmann, 1991.
Prevention of experimentally induced whirling
disease in rainbow trout Oncorhynchus
mykiss by fumagillin. Dis. Aquat. Org.,
10:109-113.
Golomazou E., Karagouni E. and F.
Athanassopoulou, 2004. The most important
Myxosporean parasite species affecting cul-
tured Mediterranean fish. J. Hel. Vet. Med.
Soc., 55:342-351 (Greek, with English
abstract).
Haberkorn A., 1996. Chemotherapy of
human and animal coccidioses: state and per-
spectives. Parasitol. Res., 82:193-199.
Hamamoto K., Koike R. and Y. Machida,
2000. Bioavailability of amprolium in fasting
and nonfasting chickens after intravenous and
oral administration. J. Vet. Pharmacol. Ther.,
23:9-12. 
Hedrick R.P., Groff J.M., Foley P. and T.
McDowell, 1988. Oral administration of
fumagillin protects Chinook salmon
Oncorhynchus tshawytscha from experimen-
tally-induced proliferative kidney disease. Dis.
Aquat. Org., 4:165-168.
Hedrick R.P., Groff J.M. and D.V. Baxa, 1991.
Experimental infections with Enterocytozoon
salmonis Chilmonczyk, Cox, Hedrick
(Microsporea): an intranuclear microsporidium
from Chinook salmon Oncorhynchus tshawyts-
cha. Dis. Aquat. Org., 10:103-108 
Higgins M.J. and M.L. Kent, 1998. TNP-470,
the analogue of fumagillin-DCH, controls PKX
in naturally infected sockeye salmon,
Oncorhynchus nerka (Walbaum), underyear-
lings. J. Fish Dis., 21:455-457.
Karagouni E., Athanassopoulou F.,
Tsagozis P., Ralli E., Moustakareas T.,
Lytra K. and E. Dotsika, 2005. The impact of
a successful anti-myxosporean treatment on
the phagocyte functions of juvenile and adult
Sparus aurata L. Int. J. Immunopathol.
Pharmacol., 18:121-132. 
Kent M.L. and S. Dawe, 1994. Efficacy of
fumagillin DCH against experimentally
induced Loma salmonae infections. Dis.
Aquat. Org., 20:231-233.
Le-Breton A. and A. Marques, 1995.
Occurrence of a histozoic Myxidium in two
marine cultured species: Puntazzo puntazzo
and Pagrus major. Bull. Eur. Assoc. Fish
Pathol., 15:210-212.
Molnar K., 1993. Recent achievements in the
chemotherapy of myxosporean infections of
fish. Acta Vet. Hung., 41:51-58.
Golomazou et al.
Molnar K., Baska F. and C. Szekely, 1987.
Fumagillin, an efficacious drug against renal
sphaerosporosis of the common carp. Dis.
Aquat. Org., 2:187-190.
Rigos G., Grigorakis K., Christophilo-
giannis P., Nengas I. and M. Alexis, 1997.
Ceratomyxa spp. (Myxosporea) infections in
cultured common dentex from Greece. Bull.
Eur. Assoc. Fish Pathol., 17:174-176.
Rigos G., Christophilogiannis P., Yagnisi
M., Andriopoulou A., Koutsodimou M.,
Nengas J. and M. Alexis, 1999. Myxo-
sporean infections in Greek mariculture.
Aquac. Int., 7:361-364.
Roberts R.J., 1989. Fish Pathology. Bailliere-
Tindall, London. 467 pp.
Roberts R.J. and C.J. Shepherd, 1997.
Handbook of Trout and Salmon Diseases.
Fishing News Books, Oxford. 162 pp.
Russell J.B. and A.J. Houlihan, 2003.
Ionophore resistance of ruminal bacteria and
its potential impact on human health. FEMS
Microbiol. Rev., 27:65-74.
Sitja-Bobadilla A. and P. Alvarez-Pellitero,
1992. Effect of fumagillin treatment on sea
bass Dicentrarchus labrax parasitized by
Sphaerospora testicularis (Myxosporea:
Bivalvulida). Dis. Aquat. Org., 14:171-178. 
Sitja-Bobadilla A., Franco-Sierra A. and P.
Alvarez-Pellitero, 1992. Sphaerospora (Myxo-
sporea: Bivalvulidae) infection in cultured gilt-
head sea bream Sparus aurata L: a preliminary
report. J. Fish Dis., 15: 339-343. 
Speare D., Athanassopoulou F., Daley J.
and J.G. Sanchez, 1999. A preliminary inves-
tigation of alternatives to fumagillin for the
treatment of Loma salmonae in rainbow trout.
J. Comp. Pathol., 121:241-248.
Szekely C., Molnar K. and F. Baska, 1988.
Efficacy of fumagillin against Myxidium giardi
Cepede, 1906 infection of the European eel
(Anguilla): new observations on myxidiosis of
imported glass eels. Acta Vet. Hung., 36:239-
246. 
Tojo J.L. and M.T. Santamarina, 1998a.
Oral pharmacological treatments for parasitic
diseases of rainbow trout Oncorhynchus
mykiss. I. Hexamita salmonis. Dis. Aquat.
Org., 33:51-56.
Tojo J.L. and M.T. Santamarina, 1998b.
Oral pharmacological treatments for parasitic
diseases of rainbow trout Oncorhynchus
mykiss. II. Gyrodactylus sp. Dis. Aquat. Org.,
33:187-193.
Tojo J.L. and M.T. Santamarina, 1998c. Oral
pharmacological treatments for parasitic dis-
eases of rainbow trout Oncorhynchus mykiss.
III. Ichthyobodo necator. Dis. Aquat. Org.,
33:195-199.
Yokoyama H., Ogawa K. and H.
Wakabayashi, 1990. Chemotherapy with
fumagillin and toltrazuril against kidney
enlargement disease of goldfish caused by
myxosporean Hoferellus carassii. Fish
Pathol., 25:157-163. 
Yokoyama H., Liyanage Y.S., Sugai A. and
H. Wakabayashi, 1999. Efficacy of fumagillin
against haemorrhagic thelohanellosis caused
by Thelohanellus hovorkai (Myxosporea:
Myxozoa) in coloured carp, Cyprinus carpio L.
J. Fish Dis., 22:243-245.
169Effects of anti-coccidial drugs on Enteromyxum leei infection in seabream
